OT Pharma Fund VII, LLC
Ot · adviser of record: OT Management, LLC · 2021 vintage
OT Pharma Fund VII, LLC is a 2021 venture fund managed by Ot, with $9.4mm raised (Form D, amount sold). It reported $4.8mm in gross assets at year-end 2023, 0.51x its size, against a peak of $9.6mm in 2021.
- Latest value held
- $4.8mm year-end 2023
- Peak
- $9.6mm year-end 2021
- Fund size
- $9.4mm Form D, amount sold
- Held vs. size
- 0.51x peak 1.02x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2023 | $4.8mm | 0.51x | -49% |
| 2022 | $9.4mm | 1.00x | -2% |
| 2021 | $9.6mm | 1.02x | – |
Other funds from Ot
- OT Pharma Fund VIII, LLC 2023
- OT EM Fintech Fund I, LLC 2022
- OT MBC Fund I, LLC 2022
- OT Dapper Fund I, LP 2021
- Zola Global Investors I, LLC 2021
- OT Asia Fintech Fund I, LLC 2021
- OT Bioag Fund III, LLC 2021
- Zola Ventures Fund I, LLC 2021
- QLT Holdings, LLC 2021
- Otgc Fintech Fund I, LLC 2021
- OT Hsa Fund I, LLC 2021
- OT Proptech Fund I, LLC 2021
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-9032570244. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.